Delivery Order SPE2DR25D2108-SPE2DR26F6RN8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under a competitive procurement process. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,958.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was awarded without set-aside designations through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $14,683.76 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on a firm fixed price basis. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025, and no set-aside designation was used in this competitive procurement. Performance will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,085.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens on September 26, 2025, with completion targeted for September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal pharmaceutical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,453.70 on November 18, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens with an ultimate completion date of November 19, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, AmerisourceBergen's headquarters location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,733.38 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on a firm fixed-price basis. The award, made on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen will perform from its corporate office location in Conshohocken, Pennsylvania, fulfilling this pharmaceutical delivery order as part of the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,880.84 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,614.63 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on December 10, 2025, with completion scheduled for December 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. The product will be performed at the contractor's facility in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,788.24 for Trulicity 1.5 mg/0.5 ml pens on October 17, 2025, with completion targeted for October 20, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,630.84 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 23, 2025, with an ultimate completion date of April 24, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement of pharmaceutical products to support federal...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6RN8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,765.84 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on a firm fixed-price basis. The contract, which was competitively awarded without a set-aside designation, has an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen demonstrates significant capability in fulfilling federal medical procurement requirements across multiple therapeutic domains through competitive contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 12/10/25 |